Estimation of Effective Dose 95 (ED95) of Intrathecal Isobaric 2-chloroprocaine (2-CP) Based on the Height (cm) of a Patient Undergoing Ambulatory Knee Arthroscopy
Launched by CENTRE HOSPITALIER UNIVERSITAIRE SAINT PIERRE · Mar 19, 2019
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • signed informed consent
- • scheduled outpatient knee arthroscopy
- • between 18 and 80 years old
- • American Society of Anesthesiologists physical status (ASA) \< III
- • Height between 150 and 195 cm
- Exclusion Criteria:
- • cardiac pathology (such as heart failure, aortic stenosis)
- • coagulation disorder (International Normalized Ratio (INR) \> 1.3, platelets\<80.000/mm3)
- • known allergy to local anaesthetics
- • central and peripheral neuropathies
- • patient's refusal
About Centre Hospitalier Universitaire Saint Pierre
The Centre Hospitalier Universitaire Saint Pierre (CHU Saint Pierre) is a leading academic medical center dedicated to advancing healthcare through innovative clinical research and high-quality patient care. Located in Brussels, Belgium, this institution is known for its multidisciplinary approach, integrating cutting-edge medical practices with comprehensive training for healthcare professionals. With a focus on improving patient outcomes, CHU Saint Pierre actively sponsors and conducts a wide range of clinical trials, fostering collaboration among researchers, clinicians, and industry partners to address pressing medical needs and enhance therapeutic options. Its commitment to ethical standards and rigorous scientific methodologies ensures the integrity and reliability of its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Braine L'alleud,, , Belgium
Patients applied
Trial Officials
Emmanuel Guntz, MD, PhD
Principal Investigator
Université Libre de Bruxelles (ULB), Braine-l'Alleud Hospital
Emmanuel Guntz
Principal Investigator
Université Libre de Bruxelles (ULB), Braine-l'Alleud Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials